FCX•prnewswire•
Investor Alert: Robbins LLP Informs Investors of the Skye Bioscience, Inc. Class Action
Summary
SAN DIEGO, Nov. 18, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Skye Bioscience, Inc. (NYSE: FCX) securities between November 4, 2024 and October 3, 2025. Skye is a clinical stage...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 18, 2025 by prnewswire